Astex Bags Another Cancer Deal With MSD, This Time For ‘Undruggable’ p53 Target

Gets $35m Upfront

guardian angel image
TP53 Has Been Described As The Guardian Of The Genome • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Deals

More from Business